Results 151 to 160 of about 971 (198)
Ca-A Cancer Journal for Clinicians, 1992 Some of the next articles are maybe not open access.
Related searches:
Related searches:
Hematology/Oncology Clinics of North America, 2022
The neurofibromatoses are a group of genetic disorders that cause development of nervous system tumors as well as various other tumor and systemic manifestations. Neurofibromatosis type 1 is the most prevalent of these conditions and has the most variable phenotype and highest risk of malignant tumor formation.
Justin T, Jordan, Scott R, Plotkin
openaire +2 more sources
The neurofibromatoses are a group of genetic disorders that cause development of nervous system tumors as well as various other tumor and systemic manifestations. Neurofibromatosis type 1 is the most prevalent of these conditions and has the most variable phenotype and highest risk of malignant tumor formation.
Justin T, Jordan, Scott R, Plotkin
openaire +2 more sources
Neurologie up2date, 2022
Die Symptome einer Neurofibromatose können in allen Altersklassen erstmals auftreten, häufig bereits in den ersten 3 Lebensdekaden, teilweise mit sehr langsamer Entwicklung über Jahrzehnte oder rasch progredient innerhalb weniger Monate. Unter anderem diese unterschiedliche
Cordula Matthies +2 more
openaire +1 more source
Die Symptome einer Neurofibromatose können in allen Altersklassen erstmals auftreten, häufig bereits in den ersten 3 Lebensdekaden, teilweise mit sehr langsamer Entwicklung über Jahrzehnte oder rasch progredient innerhalb weniger Monate. Unter anderem diese unterschiedliche
Cordula Matthies +2 more
openaire +1 more source
2023
Abstract The neurofibromatoses include neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. These are genetically distinct tumor suppressor syndromes with increased incidence of central and peripheral nervous system tumors and an autosomal dominant inheritance pattern. It is important to recognize these
Kun-Wei Song, Scott R. Plotkin
openaire +1 more source
Abstract The neurofibromatoses include neurofibromatosis type 1 (NF1), neurofibromatosis type 2 (NF2), and schwannomatosis. These are genetically distinct tumor suppressor syndromes with increased incidence of central and peripheral nervous system tumors and an autosomal dominant inheritance pattern. It is important to recognize these
Kun-Wei Song, Scott R. Plotkin
openaire +1 more source
The neurofibromatoses. An overview
The Italian Journal of Neurological Sciences, 1999The last two decades have seen clinical and molecular delineation of the different forms of neurofibromatosis. Differentiation of these forms is not just an academic exercise: their natural history, management and genetic counselling are quite different.
RUGGIERI, MARTINO, HUSON SM
openaire +3 more sources
Practical Neurology, 2010
Neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2) are inherited autosomal dominant disorders that have a significant impact on the nervous system and predispose to tumour formation. The current nomenclature makes NF1 and NF2 awkward bedfellows because they are clinically and genetically separate disorders. Neurofibromas are characteristic of NF1,
openaire +2 more sources
Neurofibromatosis 1 (NF1) and neurofibromatosis 2 (NF2) are inherited autosomal dominant disorders that have a significant impact on the nervous system and predispose to tumour formation. The current nomenclature makes NF1 and NF2 awkward bedfellows because they are clinically and genetically separate disorders. Neurofibromas are characteristic of NF1,
openaire +2 more sources
2005
Abstract Three clinically and genetically distinct diseases are classified as neurofibromatoses: neurofibromatosis 1 (NF1), neurofibromatosis 2 (NF2) and schwannomatosis. The inclusion of these three conditions in a single group reflects the fact that they share certain clinical features, but it is important to distinguish each disease ...
openaire +1 more source
Abstract Three clinically and genetically distinct diseases are classified as neurofibromatoses: neurofibromatosis 1 (NF1), neurofibromatosis 2 (NF2) and schwannomatosis. The inclusion of these three conditions in a single group reflects the fact that they share certain clinical features, but it is important to distinguish each disease ...
openaire +1 more source
New insights into the neurofibromatoses
Current Opinion in Neurology, 1994The two neurofibromatoses, neurofibromatosis type 1 (NF1) and type 2 (NF2), have been greatly advanced by the cloning of their respective disease genes. Although NF1 and NF2 are clinically distinct disorders, they represent diseases caused by disruption of tumor suppressor genes.
openaire +2 more sources